ReviewCardiovascular diabetology2023

Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM).

Pierre Gourdy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.